Amgen, one of several biotechnology companies that have been expanding operations in Holly Springs, is poised to announce ...

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Amgen Inc. (AMGN), Eaton Corp. plc ...

Amgen Inc. closed $68.59 short of its 52-week high ($346.85), which the company reached on July 25th.

While most of this collection of Dow Industrials is too pricey and reveals only skinny dividends, one of the ten lowest ...

State and local officials are poised to announce a major economic development deal -- one that could bring hundreds of jobs to Holly Springs, people familiar with the deal told WRAL News.

The randomized clinical trial showed that Zepbound patients achieved 47% more relative weight loss than Wegovy patients.

The struggling biotech company is looking to break into the lucrative hepatitis C market with the promise of an easier ...

Eli Lilly & Co. Inc.'s stock (LLY) rose 2.3% Wednesday, after the company said its Zepbound weight-loss drug was more effective than rival Novo Nordisk's Wegovy in a head-to-head study.

The donation to Rush’s orthopedic department, the largest ever, creates four new endowed positions and programs.

Shares of Amgen Inc. AMGN inched 0.08% higher to $278.32 Tuesday, on what proved to be an all-around mixed trading session ...

Following a pair of similar deals in January and June, Coherus BioSciences has netted itself a hefty chunk of change for the ...